No adverse events (including signs of infection) were observed following treatment with anti-CD14 antibody either in vivo or at postmortem in any of the present studies (postmortem examinations performed for all animals, including all 102 mice following treatment with anti-CD14) (Supplemental Table S1). Here, CD14 is linked to infection.